The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationClinical Practice Guidelines We Can Trust
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, & Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,081
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Lammer, J., Malagari, K., Vogl, T., Pilleul, F., Denys, A., Watkinson, A., Pitton, M., Sergent, G., Pfammatter, T., Terraz, S., et al. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9711-7 · Cited by 1,557
A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B
Chang, T.-T., Gish, R. G., de Man, R., Gadano, A., Sollano, J., Chao, Y.-C., Lok, A. S., Han, K.-H., Goodman, Z., Zhu, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051285 · Cited by 1,444
Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
Lai, C.-L., Shouval, D., Lok, A. S., Chang, T.-T., Cheinquer, H., Goodman, Z., DeHertogh, D., Wilber, R., Zink, R. C., Cross, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051287 · Cited by 1,188
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Liaw, Y.-F., Kao, J.-H., Piratvisuth, T., Chan, H. L. Y., Chien, R.-N., Liu, C.-J., Gane, E., Locarnini, S., Lim, S.-G., Han, K.-H., et al. (2012) · Hepatology International · doi:10.1007/s12072-012-9365-4 · Cited by 1,038
Perrillo, R. P., Schiff, E. R., Davis, G. L., Bodenheimer, H. C., Lindsay, K., Payne, J., Dienstag, J. L., O'Brien, C., Tamburro, C., Jacobson, I. M., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008023230503 · Cited by 840
Tiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H. A., Wirtz, S., Becker, C., Atreya, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16432 · Cited by 828
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
Lok, A. S. F., Liang, R. H. S., Chiu, E. K. W., Wong, K.-L., Chan, T.-K., & Todd, D. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90599-g · Cited by 827
Weinbaum, C. M., Mast, E. E., & Ward, J. W. (2009) · Hepatology · doi:10.1002/hep.22882 · Cited by 815
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
Lok, A. S. F., Lai, C.-L., Leung, N., Yao, G.-B., Cui, Z.-Y., Schiff, E. R., Dienstag, J. L., Heathcote, E. J., Little, N. R., Griffiths, D. A., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.033 · Cited by 764
Yeo, W., Chan, T. C., Leung, N. W. Y., Lam, W. Y., Mo, F. K. F., Chu, M. T., Chan, H. L. Y., Hui, E. P., Lei, K. I. K., Mok, T. S. K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0182 · Cited by 636
Chang, T.-T., Lai, C.-L., Yoon, S. K., Lee, S. S., Coelho, H. S. M., Carrilho, F. J., Poordad, F., Halota, W., Horsmans, Y., Tsai, N., et al. (2010) · Hepatology · doi:10.1002/hep.23327 · Cited by 588
Reactivation of hepatitis B # †
Hoofnagle, J. H. (2009) · Hepatology · doi:10.1002/hep.22945 · Cited by 570
Perrillo, R. P., Gish, R., & Falck-Ytter, Y. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.038 · Cited by 504
Self-citationLoomba, R., Rowley, A., Wesley, R., Liang, T. J., Hoofnagle, J. H., Pucino, F., & Csako, G. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-7-200804010-00008 · Cited by 459
Lau, G. K. K., Yiu, H. H. Y., Fong, D. Y. T., Cheng, H.-C., Au, W.-Y., Lai, L. S. F., Cheung, M., Zhang, H.-Y., Lie, A., Ngan, R., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.026 · Cited by 458
Perrillo, R. P. (2001) · Gastroenterology · doi:10.1053/gast.2001.22461 · Cited by 421
American Gastroenterological Association
(1958) · The Lancet · doi:10.1016/s0140-6736(58)92067-1 · Cited by 350
Huang, Y.-H., Hsiao, L.-T., Hong, Y.-C., Chiou, T.-J., Yu, Y.-B., Gau, J.-P., Liu, C.-Y., Yang, M.-H., Tzeng, C.-H., Lee, P.-C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5938 · Cited by 326
Yeo, W., Zee, B., Zhong, S., Chan, P. K. S., Wong, W.-L., Ho, W. M., Lam, K. C., & Johnson, P. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601699 · Cited by 312
Hsu, C., Hsiung, C. A., Su, I.-J., Hwang, W.-S., Wang, M.-C., Lin, S.-F., Lin, T.-H., Hsiao, H.-H., Young, J.-H., Chang, M.-C., et al. (2008) · Hepatology · doi:10.1002/hep.22106 · Cited by 305
Cheng, A., Hsiung, C. A., Su, I., Chen, P., Chang, M., Tsao, C.-J., Kao, W.-Y., Uen, W., Hsu, C., Tien, H., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50220 · Cited by 289
Hsu, C., Tsou, H.-H., Lin, S.-J., Wang, M.-C., Yao, M., Hwang, W.-L., Kao, W.-Y., Chiu, C.-F., Lin, S.-F., Lin, J., et al. (2014) · Hepatology · doi:10.1002/hep.26718 · Cited by 277
Pérez-Alvarez, R., Díaz-Lagares, C., García-Hernández, F., Lopez-Roses, L., Brito-Zerón, P., Pérez-de-Lis, M., Retamozo, S., Bové, A., Bosch, X., Sanchez-Tapias, J.-M., et al. (2011) · Medicine · doi:10.1097/md.0b013e3182380a76 · Cited by 276
Systemic effects of intra-articular corticosteroids
Habib, G. S. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1135-x · Cited by 273
Woo, G., Tomlinson, G., Nishikawa, Y., Kowgier, M., Sherman, M., Wong, D. K. H., Pham, B., Ungar, W. J., Einarson, T. R., Heathcote, E. J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.042 · Cited by 259
Kitrinos, K. M., Corsa, A., Liu, Y., Flaherty, J., Snow-Lampart, A., Marcellin, P., Borroto-Esoda, K., & Miller, M. D. (2014) · Hepatology · doi:10.1002/hep.26686 · Cited by 226
Jang, J. W., Choi, J. Y., Bae, S. H., Yoon, S. K., Chang, I. U., Kim, C. W., Cho, S. H., Han, J. Y., & Lee, Y. S. (2006) · Hepatology · doi:10.1002/hep.21024 · Cited by 198
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
Yeo, W., Lam, K. C., Zee, B., Chan, P. S. K., Mo, F. K. F., Ho, W. M., Wong, W. L., Leung, T. W. T., Chan, A. T. C., Ma, B., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh430 · Cited by 177
Immunosuppression and HBV Reactivation
Shibolet, O., & Shouval, D. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1345722 · Cited by 176
Tur-Kaspa, R., Shaul, Y., Moore, D. D., Burk, R. D., Okret, S., Poellinger, L., & Shafritz, D. A. (1988) · Virology · doi:10.1016/0042-6822(88)90127-4 · Cited by 172
Artz, A. S., Somerfield, M. R., Feld, J. J., Giusti, A. F., Kramer, B. S., Sabichi, A. L., Zon, R. T., & Wong, S. L. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.0673 · Cited by 158
Matsue, K., Kimura, S., Takanashi, Y., Iwama, K., Fujiwara, H., Yamakura, M., & Takeuchi, M. (2010) · Cancer · doi:10.1002/cncr.25253 · Cited by 152
Tamori, A., Koike, T., Goto, H., Wakitani, S., Tada, M., Morikawa, H., Enomoto, M., Inaba, M., Nakatani, T., Hino, M., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-010-0367-5 · Cited by 149
for the REPENTINA study, G. G. (. E. D. E. D. C. Y. C. U., Loras, C., Saro, C. M., Gónzalez‐Huix, F., Mínguez, M., Merino, O., Gisbert, J. P., Barrio, J., Bernal, A., Gutiérrez, A., et al. (2008) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.4 · Cited by 146
Pol, S., & Lampertico, P. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2012.01602.x · Cited by 144
Chiu, H., Chen, C., Wu, M., Cheng, Y. ‐., & Tsai, T. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12461 · Cited by 144
Schalm, S. W., Summerskill, W. H. J., Gitnick, G., & Elveback, L. R. (1976) · Gut · doi:10.1136/gut.17.10.781 · Cited by 131
Dong, H., Ni, L., Sheng, G.-F., Song, H.-L., Jian-zhong, X., & Ling, Y. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.03.010 · Cited by 117
Carroll, M. B., & Forgione, M. A. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1523-2 · Cited by 116
LeFevre, M. L., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m14-1018 · Cited by 111
The AGA Institute Process for Developing Clinical Practice Guidelines Part One: Grading the Evidence
Sultan, S., Falck–Ytter, Y., & Inadomi, J. M. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.001 · Cited by 104 · cited 1×
“Reprinted with permission from Sultan et al.(2) 216 Reddy et al Gastroenterology Vol.”
MethodSelf-citationKoo, Y. X., Tay, M., Teh, Y. E., Teng, D. K. P., Tan, D. S. W., Tan, I., Tai, D. W.-M., Quek, R. H. H., Tao, M., & Lim, S. T. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1241-0 · Cited by 104
Mori, S. (2011) · Modern Rheumatology · doi:10.1007/s10165-011-0458-z · Cited by 102
FDA: Increased HBV Reactivation Risk With Ofatumumab or Rituximab
Mitka, M. (2013) · JAMA · doi:10.1001/jama.2013.281115 · Cited by 97
Lao, X., Luo, G., Ye, L., Luo, C., Shi, M., Wang, D., Guo, R., Chen, M., Li, S., Lin, X., et al. (2013) · Liver International · doi:10.1111/liv.12112 · Cited by 95
Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy
Hwang, J. P., Fisch, M. J., Zhang, H., Kallen, M. A., Routbort, M. J., Lal, L. S., Vierling, J. M., & Suarez-Almazor, M. E. (2012) · Journal of Oncology Practice · doi:10.1200/jop.2011.000450 · Cited by 94
Ikeda, K., Shiga, Y., Takahashi, A., Kai, T., Kimura, H., Takeyama, K., Noji, H., Ogawa, K., Nakamura, A., Ohira, H., et al. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/14639230500236818 · Cited by 92
Yeo, W., Ho, W. M., Hui, P., Chan, P. K. S., Lam, K. C., Lee, J. J., & Johnson, P. J. (2004) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-0725-1 · Cited by 91
Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy
Pei, S., Ma, M., Wang, M., Kuo, C., Rau, K.-M., Su, C.-Y., & Chen, C. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1405-6 · Cited by 90
Liao, C., Lee, C., Wu, H., Wang, M., Lu, S., & Eng, H. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03239.x · Cited by 89
Tan, J. Y., Zhou, J., Zhao, P., & Wei, J. (2012) · Clinical Rheumatology · doi:10.1007/s10067-012-1988-2 · Cited by 80
Altunöz, M. E., Şenateş, E., Yeşıl, A., Çalhan, T., & Övünç, A. O. K. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1980-8 · Cited by 77
Papa, A., Felice, C., Marzo, M., Andrisani, G., Armuzzi, A., Covino, M., Mocci, G., Pugliese, D., Vitis, I. D., Gasbarrini, A., et al. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.03.001 · Cited by 75
Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor
Lai, G.-M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i8.1318 · Cited by 72
Jang, J. W., Kwon, J. H., You, C. R., Kim, J.-D., Woo, H. Y., Bae, S. H., Choi, J. Y., Yoon, S. K., & Chung, K. W. (2011) · Antiviral Therapy · doi:10.3851/imp1840 · Cited by 69
Day, F. L., Karnon, J. D., & Rischin, D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.1635 · Cited by 63
Kang, B. W., Lee, S. J., Moon, J. H., Kim, S.-N., Chae, Y. S., Kim, J. G., Hwang, Y.-J., & Sohn, S. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0386-2 · Cited by 54
Chou, R., Dana, T., Bougatsos, C., Blazina, I., Khangura, J., & Zakher, B. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2837 · Cited by 53
Shi, Y., He, J., Wu, W., Huang, J., Yang, Y., Sheng, J., Yu, L., Chen, Z., & Jia, H. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30998-6 · Cited by 52
Long, M., Jia, W., Li, S., Jin, L., Wu, J., Rao, N., Feng, H., Kai, C., Deng, H., Liu, F., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1455-9 · Cited by 51
Oh, M. J., & Lee, H. J. (2013) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2013.19.1.51 · Cited by 39
Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
Petersen, J., & Buti, M. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.52 · Cited by 27
Lee, H. J., Kim, D. Y., Keam, B., Lee, J., Han, S., Oh, D., Yoon, J., Kim, T., Kim, Y. J., Lee, K. W., et al. (2012) · Breast Cancer · doi:10.1007/s12282-012-0417-3 · Cited by 17
Raman, G., Kitsios, G. D., Moorthy, D., Hadar, N., Dahabreh, I. J., O’Donnell, T. F., Thaler, D. E., Feldmann, E. G., & Lau, J. T. F. (2012) · Cited by 11
Cited by
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Mack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983
“Patients on immunosuppressive agents are at risk for reactivation of HBV infection, and guidelines have been developed recommending routine pretreatment screening of patients for hepatitis B surface antigen (HBsAg) and antibodies to hepatitis B core antigen (anti-HBc).(296-299) Based on the serological profile (HBsAg-…”
BackgroundStravitz, R. T., & Lee, W. M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31894-x · Cited by 844
Metadata
- Authors
- Reddy, K. R., Beavers, K. L., Hammond, S. P., Lim, J. K., & Falck-Ytter, Y. T.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 148
- Issue
- 1
- Pages
- 215-219
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1994351795
- Cited by
- 861
- References
- 68
- FWCI
- 44.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.